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Abstract
Advanced tissue engineered heart valves must be constructed from multiple materials to better 
mimic the heterogeneity found in the native valve. The trilayered structure of aortic valves 
provides the ability to open and close consistently over a full human lifetime, with each layer 
performing specific mechanical functions. The middle spongiosa layer consists primarily of 
proteoglycans and glycosaminoglycans, providing lubrication and dampening functions as the 
valve leaflet flexes open and closed. In this study, hyaluronan hydrogels were tuned to perform the 
mechanical functions of the spongiosa layer, provide a biomimetic scaffold in which valve cells 
were encapsulated in 3D for tissue engineering applications, and gain insight into how valve cells 
maintain hyaluronan homeostasis within heart valves. Expression of the HAS1 isoform of 
hyaluronan synthase was significantly higher in hyaluronan hydrogels compared to blank-slate 
poly(ethylene glycol) diacrylate (PEGDA) hydrogels. Hyaluronidase and matrix metalloproteinase 
enzyme activity was similar between hyaluronan and PEGDA hydrogels, even though these 
scaffold materials were each specifically susceptible to degradation by different enzyme types. 
KIAA1199 was expressed by valve cells and may play a role in the regulation of hyaluronan in 
heart valves. Cross-linked hyaluronan hydrogels maintained healthy phenotype of valve cells in 
3D culture and were tuned to approximate the mechanical properties of the valve spongiosa layer. 
Therefore, hyaluronan can be used as an appropriate material for the spongiosa layer of a proposed 
laminate tissue engineered heart valve scaffold.
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INTRODUCTION
A variety of tissue engineering strategies are being investigated to address the need for a 
living replacement heart valve1 that would mitigate the limitations of currently available 
mechanical and bioprosthetic valves.2,3 A tissue engineered heart valve would be 
constructed of a temporary biocompatible scaffold and seeded with autologous cells either in 
vitro or in vivo. Over time, the cells would degrade the scaffold and replace it with secreted 
extracellular matrix (ECM), resulting in a tissue that would ideally resemble a native heart 
valve in both structure and function. This goal has not yet been realized, however, as many 
previous attempts have resulted in leaflet contraction and fibrous tissue.4 There is growing 
interest in developing a more biomimetic scaffold that will improve on previous designs by 
giving seeded cells local cues to direct remodeling in a way that recreates native valve 
architecture.5
Heart valves have distinct layers, distinguished by their ECM composition. On the outflow 
side, the fibrosa layer, which primarily consists of circumferentially aligned collagen fibers, 
gives the valve strength to resist the pressure gradient across the valve. The ventricularis 
layer is located on the inflow side of the pulmonary and aortic valves and is rich in elastic 
fibers. Between the fibrosa and the ventricularis is the spongiosa layer, consisting of mostly 
glycosaminoglycans (GAGs) and proteoglycans (PGs). The spongiosa layer provides 
compressive resistance during coaptation between the leaflets, lubrication between the stiffer 
outer layers during valve flexure, and a dampening effect on leaflet motion.6,7 Recently, 
several tissue engineering approaches to design scaffolds that mimic the layered structure of 
the natural valve have been reported.8–12 In this work, we examined the polymer hyaluronan 
with two motivations in mind: first, as a part of a broader strategy to create a layered tissue 
engineered heart valve scaffold; second, to better understand how valve interstitial cells 
(VICs) maintain hyaluronan homeostasis within the spongiosa layer of heart valves.
Hyaluronan is a naturally occurring chain of repeating disaccharides that makes up 60% of 
the GAGs in valve tissue.13 Hyaluronan has been used as a substrate for studying the 
behavior of many different cell types in both 2D and 3D,14 and also plays an important role 
in cardiac valve development.15 Valve cells interact with hyaluronan through several 
different receptors and enzymes. CD44 is the primary cell surface receptor through which 
hyaluronan influences cells;16 it participates in the transduction of intracellular signaling for 
cell proliferation, survival, and movement.17 The receptor for hyaluronic acid-mediated 
motility (RHAMM or CD168) can be found in the cytosol or on the cell membrane and 
shares some of the same intracellular signaling pathways with CD44.17 Cells control 
hyaluronan synthesis and degradation through enzymes, predominately the hyaluronan 
synthases HAS1, HAS2, and HAS3 and the hyaluronidases HYAL1 and HYAL2. Finally, the 
recently discovered protein KIA1199 has been shown to play a role in hyaluronan 
endocytosis and degradation. KIAA1199 was originally investigated for its role in hearing 
loss18 and has been observed to be upregulated in human cancers.19 More recently, 
KIAA1199 has been shown to be responsible for hyaluronan catabolism in human and 
mouse fibroblasts, independent of CD44 and hyaluronidase enzymes.20,21
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To gain insight into the extent of biochemical signaling from the hyaluronan scaffold, we 
directly compared VIC behavior in cross-linked hyaluronan hydrogels to enzymatically 
degradable, but otherwise, biochemically inert, poly(ethylene glycol) diacrylate (PEGDA) 
hydrogels; both PEGDA and hyaluronan hydrogels have been previously investigated as 3D 
scaffolds for VICs.22–30 We used these materials to evaluate hydrogels for the mechanical 
requirements of the spongiosa layer and to study how VICs alter expression of hyaluronan-
related proteins in response to the biochemical makeup of the scaffold.
EXPERIMENTAL SECTION
Materials and Methods
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless indicated 
otherwise.
Valve Interstitial Cell Isolation and Culture
VICs were harvested from aortic valve leaflets of fresh porcine hearts obtained from a local 
commercial abattoir (Fisher Ham and Meats, Spring, TX) according to a validated 
protocol.31 To loosen endothelial cells, dissected leaflets were digested in a collagenase 2 
solution (500 U/mL, Worthington Biochemical, Lakewood, NJ) for 30 min at 37 °C. After 
the endothelial cells were scraped from both surfaces of the leaflets, the residual leaflet 
tissue was minced. The minced tissue was digested in a collagenase 3 solution (300 U/mL, 
Worthington Biochemical) for 4 h at 37 °C. The solution was passed through a 70 µm cell 
strainer and then VICs were plated in tissue culture polystyrene (TCPS) flasks. VICs were 
cultured in a standard humidified incubator (37 °C, 5% CO2) in 50:50 DMEM/F12 media 
(Corning, Tewksbury, MA) with 10% bovine growth serum (BGS, Lonza, Walkerville, MD), 
1% 1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, Thermo Fisher 
Scientific, Waltham, MA), and 1% penicillin/streptomycin/ amphotericin (Corning). For 
consistency, all VICs were frozen after passage 1 and used in passages 2–3. VICs were used 
from three separate harvests with cells pooled from all aortic valve leaflets of six porcine 
hearts during each harvest.
PEG-Peptide Conjugation
The peptide sequence GGGPQG↓ IWGQGK (PQ) was prepared using solid phase synthesis 
(APEX 396, Aapptec, Louisville, KY) and verified using matrix-assisted laser desorption/
ionization time-of-flight (MALDI-TOF) mass spectrometry (Autoflex, Bruker Daltonics, 
Billerica, MA). RGDS peptide was purchased from American Peptide Company (Vista, 
CA). Acryloyl-PEG-RGDS (PEG-RGDS) and acryloyl-PEG-PQ-PEG-acryloyl (PEG-PQ) 
were conjugated as previously described.25 Briefly, 3400 Da acryloyl-PEG-succinimidyl 
valerate (PEG-SVA, Laysan Bio, Arab, AL) was reacted with RGDS at 1:1.2 ratio or PQ at 
2.1:1 ratio overnight at pH 8.0. The products were dialyzed for 48 h using a 3500 Da 
molecular weight cutoff dialysis membrane. Dialyzed PEG-peptide conjugates were then 
sterile filtered using a 0.22 µm Steriflip 50 mL tube filter (EMD Millipore, Billerica, MA), 
frozen, and lyophilized. Gel permeation chromatography equipped with UV and evaporative 
light-scattering detectors (Varian, Palo Alto, CA) was used to confirm PEG–peptide 
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conjugation, while proton NMR (Avance III HD 600 MHz, Bruker Daltonics) was used to 
confirm intact acrylate groups on the peptide-conjugated polymer.
Modification of Hyaluronan
Hyaluronan was modified with either methacrylate or acrylate groups for photoinitiated free-
radical cross-linking. Hyaluronan was acrylated using a modified version of a published 
protocol.32 First, 35 kDa sodium hyaluronate (NaHA, Lifecore Biomedical, Chaska, MN) 
underwent cation exchange (sodium to tetrabutylammonium) so that it could be dissolved in 
organic solvents.33 Briefly, Dowex resin (Dowex 50WX8 H+ form, 200–400 mesh) was 
washed in diH2O before mixing with 1% w/v NaHA in water overnight at room temperature 
to capture the Na+ ions. After 24 h, a Buchner funnel was used to filter the Dowex from the 
HA solution. The HA solution was titrated to pH 8.0 using 0.1 M tetrabutylammonium 
hydroxide (TBA-OH) and then lyophilized. The amount of TBA in the product was 
determined from proton NMR.
Acrylation of hyaluronan-tetrabutylammonium (HA-TBA) was performed under argon using 
acryloyl chloride (A-Cl), as shown in Scheme 1. HA-TBA (∼100 mg) was dissolved in a 
round-bottom 3-neck flask at 1% w/v in anhydrous dimethylformamide (DMF). Anhydrous 
triethylamine (TEA) was added to the flask at a molar ratio of 4:1 TEA/A-Cl. The A-Cl was 
diluted to 10% v/v in DMF and then added to the reaction flask dropwise to achieve a final 
molar ratio of 0.9:1 A-Cl/(HA-TBA disaccharide). The reaction was left overnight at room 
temperature, protected from light. Acrylated hyaluronan (AHA) was recovered by 
precipitating the reaction flask contents in cold diethyl ether. The precipitate was captured 
by filtering in a Buchner funnel through filter paper (Whatman #3, Fisher), which was then 
air-dried in the dark. The filter paper with dried AHA was submerged in diH2O for 10 min 
to dissolve the AHA.
Methacrylation of hyaluronan was accomplished following a previously described method 
with glycidyl methacrylate (GMA) in PBS34 and depicted in Scheme 2. Either 35 or 1700 
kDa NaHA (∼200 mg) was dissolved at 0.375% w/v in PBS in a round-bottom flask at room 
temperature. TEA was added to the flask at a 7:1 TEA/(HA disaccharide) molar ratio 
followed by dropwise addition of GMA to a molar ratio of 14:1 GMA/(HA disaccharide). 
The solution was allowed to react (protected from light) for 5 days at room temperature to 
produce methacrylated hyaluronan (MeHA). Both MeHA and AHA solutions were dialyzed 
extensively against 150 mM NaCl for 3 days followed by dialysis against pure water for 
three additional days. The solutions were then sterile filtered and kept sterile during 
lyophilization and experimental use.
Hydrogel Cross-Linking and VIC Encapsulation
Sterile, lyophilized polymer was dissolved in sterile filtered photoinitiator buffer consisting 
of 1.5% v/v triethanolamine (TEOA), 10 µM Eosin Y, and 0.35% v/v 1-vinyl-2-pyrillidinone 
(NVP) in HEPES buffered saline (HBS) at 4% w/v for PEG-PQ, 2% w/v for AHA, 4% w/v 
for 35 kDa MeHA, and 0.75% w/v for 1700 kDa MeHA. All solutions contained 2 mM 
PEG-RGDS. VICs were resuspended in the photoinitiator/ polymer solution at a 
concentration of 15 × 106 cells/mL and cast in 5 mm diameter × 250 µm thick PDMS molds. 
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The gels were cross-linked under ∼160 kLux of white LED light (UltraTow LED Floodlight, 
Northern Tool and Equipment, Burnsville, MN) for the amount of time determined from 
mechanical testing to produce similar stiffness hydrogels. Gels were cultured in 24 well 
plates in a standard humidified incubator. Encapsulated cells were grown in the same 50:50 
DMEM/F12 media with 10% BGS, as described above with media changes every 2–3 days.
The LIVE/DEAD cell viability/cytotoxicity kit (Thermo Fisher Scientific) with calcein AM 
and ethidium homodimer-1 reagents was used to assess cell viability at days 3 and 7 after 
encapsulation following manufacturer instructions. Briefly, cell encapsulated gels were 
incubated in media with 2 µM of calcein AM and 4 µM of ethidium homodimer-1 for 30 
min. Scaffolds were washed in PBS and immediately imaged on a confocal microscope (A1-
Rsi, Nikon, Tokyo, Japan or LSM 510, Zeiss, Oberkochen, Germany). Live and dead cells 
were counted (n = 3) using Bitplane Imaris 8.2 software (Oxford Instruments, Oxfordshire, 
U.K.) to calculate the percentage and density of alive cells.
Mechanical Characterization of Hydrogels and Aortic Valve Tissue
All hydrogel formulations were mechanically characterized in unconfined compression. 
Hydrogel disks of 6 mm diameter × 0.8 mm thickness were prepared in PDMS molds and 
allowed to swell in PBS overnight. In order to compare response of cells to hydrogel 
polymer independently of stiffness, all hydrogels were made the same stiffness through an 
iterative process. The polymer density and cross-linking time for the hydrogels were varied 
and the stiffness of the gels was tested in compression. This process was repeated until all 
hydrogel formulations were approximately equal to the target compressive modulus of 2.5 
kPa. The volume of the hydrogel disks was calculated from stereoscope images taken 
immediately after cross-linking the gels and again after swelling in PBS overnight. The 
volumetric swelling ratio was determined by dividing the increase in volume by the original 
hydrogel volume. Swollen gels were compressed to 30% strain using a Bose ELF 3200 
mechanical tester with force measured by a 1000 g load cell (Bose ELF, Eden Prairie, MN). 
The compressive modulus was calculated from a linear regression of the stress versus strain 
plot between 5% and 15% strain. Hysteresis was determined by dividing the area between 
the loading and unloading stress versus strain curves by the total area under the loading 
curve. For comparison, aortic valve tissue (5 mm diameter cylinders cut with a biopsy punch 
from the belly region of aortic valve leaflets) was tested in compression using the same 
parameters for characterization.
Enzymatic Digest of Hydrogels
PEG-PQ and AHA hydrogels were digested in both collagenase and hyaluronidase solutions 
to ensure their susceptibility and specificity for enzyme activity. Hydrogel disks of 6 mm 
diameter × 0.8 mm thick were placed in either 50 U/mL of bovine testicular hyaluronidase 
(Worthington) in PBS or 10 U/mL of collagenase 3 (Worthington) in Tris buffered saline 
(TBS) with 2 mM CaCl2 for 1, 2, 4, 12, and 24 h. Digest solution was aspirated at each time 
point and gels were frozen, lyophilized, and weighed. The mass of digested lyophilized gels 
was compared to the mass of undigested lyophilized gels.
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Immunofluorescent Staining
Protein expression was visualized using immunofluorescent (IF) staining after 14 days in 
culture. Cells were fixed in 4% paraformaldehyde for 45 min, permeabilized in 0.25% Triton 
X-100 for 15 min, and blocked in 3.5% w/v bovine serum albumin (BSA) at 4 °C overnight. 
Primary antibodies were diluted in PBS with 1% w/v BSA and 0.05% NaN3 and were 
placed on samples overnight at 4 °C. Proteins visualized via IF were αSMA (abcam ab7817; 
1:50), CD44 (Calbiochem 217594; 1:120), and RHAMM (Novus NBP1–95379; 1:120). 
Gels were washed 4× to remove unbound primary antibody over an 8 h period in PBS with 
0.01% v/v Tween 20. Secondary antibodies (AlexaFluor 488/555/633, Invitrogen Carlsbad, 
CA) were added at 1:200 concentration overnight at 4 °C. Samples were counterstained with 
DAPI and AlexaFluor 488 or 633 conjugated phalloidin (Invitrogen) for 2 h prior to imaging 
with a confocal microscope (Nikon A1-Rsi or Zeiss LSM 510).
RNA Isolation, qPCR, and Sequencing
Quantitative reverse transcriptase PCR (qPCR) was performed as previously described.25 
After 7 days in culture, cell-seeded hydrogels were placed in RNA lysis buffer (Zymo 
Research, Irvine, CA) and homogenized. mRNA was extracted with Quick-RNA MiniPrep 
Kit (Zymo Research) and transcribed to cDNA using a first Strand cDNA synthesis kit 
(Takara Bio, Otsu, Japan). The quantity and quality of mRNA was assessed using a 
Nanodrop 2000 UV–vis spectrophotometer (Thermo Fisher Scientific). Sample mRNA that 
did not have a 260/280 ratio of at least 1.8 or that was less than 5 ng/µL concentration was 
not transcribed to cDNA. A Mastercycler ep realplex qPCR system (Eppendorf, Hamburg, 
Germany) with QuantiTect SYBR Green PCR Master Mix (Clontech Laboratories, 
Mountain View, CA) was used to measure relative mRNA expression in VICs. Primer 
efficiencies and relative expression ratios were calculated using the REST 2009 program.35 
All mRNA targets and primers are listed in Supporting Information, Table S1. KIAA1199 
qPCR products were purified using a QIAquick PCR purification kit (Quiagen, Venlo, 
Netherlands) and sequenced by Lone Star Laboratories (Houston, TX).
Gelatin and Hyaluronan Zymography
Gelatin and hyaluronan substrate zymography was performed using hand cast 10% 
polyacrylamide gels containing either 0.2% w/v gelatin or 0.17 mg/ mL 1700 kDa sodium 
hyaluronate. Protein content of conditioned media from days 11–14 of VICs cultured in 
PEG-PQ and AHA hydrogels was determined using the Pierce BCA total protein assay 
(Thermo Fisher Scientific) following manufacturer’s instructions. Sample volume 
corresponding to 7 µg of protein was added to each well for zymography. After 
electrophoresis (100 V for 1 h 15 min), the polyacrylamide gels were soaked for 30 min in 
2.5% Triton X-100 for renaturing and then allowed to develop overnight at 37 °C. Gelatin 
substrate zymography developing buffer contained 50 mM Tris, 200 mM NaCl, 5 mM 
CaCl2, and 0.02% v/v Brij 35 at pH 7.8.36 Parallel sets of hyaluronan substrate zymography 
gels were developed in either the pH 7.8 gelatin zymography developing buffer or a pH 3.0 
developing buffer to detect acid-active hyaluronidases (50 mM citric acid, 50 mM dibasic 
sodium phosphate, 137 mM NaCl).37 Gelatin substrate zymograms were stained for 30 min 
with 0.5% w/v Coomassie Blue and destained in 20% isopropanol and 10% acetic acid for 2 
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h. Hyaluronan substrate zymograms were stained for 1 h with 0.5% w/v Alcian Blue in 3% 
acetic acid and destained with 7% acetic acid for 2 h. In order to visualize protein bands in 
the hyaluronan substrate polyacrylamide gels, identical electrophoresis gels were stained for 
20 min with Imperial Blue Stain (Thermo Fisher Scientific) and then destained in diH2O 
water for 1 h. ImageJ (NIH, Bethesda, MD) was used to measure the amount of enzyme 
activity in the zymograms.
Statistical Methods
Single factor ANOVA with Tukey HSD posthoc analysis was performed for all comparisons 
of material properties. Student’s t tests were used for comparison of VIC enzyme activity. 
qPCR data were evaluated using the pairwise fixed reallocation randomization test with the 
REST 2009 program. A p-value of less than 0.05 was considered significant for all tests. All 
results are reported as mean ± standard error of the mean.
RESULTS
Hyaluronan was Functionalized with Either Methacrylate or Acrylate Groups for Cross-
Linking
Sodium hyaluronate (NaHA) was functionalized with both acrylate and methacrylate groups 
for photo-cross-linking, as depicted in Schemes 1 and 2, with representative resultant 1H 
NMR spectra shown in Supporting Information, Figure S1. Hyaluronan acrylation was 
consistent and repeatable with 7.2 ± 0.7% (n = 12) degree of modification (DOM) for the 
reaction conditions used. Low (35 kDa) and high (1700 kDa) molecular weight hyaluronan 
were methacrylated with 2.6 ± 0.1% (n = 2) and 2.1% (n = 1) DOM, respectively. Details of 
DOM calculations are provided in the Supporting Information. High molecular weight 
NaHA was not successfully ion exchanged to a HA-TBA salt that was soluble in DMF, and 
therefore was functionalized with methacrylate groups in an aqueous solution.
Hyaluronan Hydrogel Mechanical Properties Can Be Optimized for a Spongiosa Layer 
Mimic
Cross-linked hydrogels were characterized by unconfined compression testing. The 
compressive modulus of valve tissue dissected from the belly region of aortic leaflets was 
5.13 ± 0.36 kPa (n = 24), which served as an approximate target elastic modulus for 
hydrogels. Hydrogel weight fraction and cross-linking time under ∼160 kLux of white light 
were varied to achieve a similar modulus among materials so that the biochemical results 
were independent of the substrate stiffness. The resulting mechanical characteristics of the 
hydrogels are shown in Table 1 and Figure 1. PEG-PQ, AHA, and 35 kDa MeHA hydrogels 
were all prepared to have approximately 2.7 kPa compressive modulus. It was not possible 
to prepare 1700 kDa MeHA hydrogels to achieve an elastic modulus greater than 1.6 kPa: 
increasing cross-linking time above 120 s had no effect and increasing weight percent over 
0.75% made cell encapsulation difficult due to high viscosity at 37 °C. In order to provide a 
comparison between 1700 kDa MeHA and PEG-PQ hydrogels of similar stiffness, PEG-PQ 
was also formulated with less cross-linking time (t = 22 s) to produce a weaker hydrogel. 
The 1700 kDa MeHA and soft PEG-PQ hydrogels were significantly less stiff than other 
formulations (n = 5; p < 0.01).
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The hysteresis of valve leaflets in compression was 64.9 ± 2.2% (n = 24). As shown in Table 
1 and Figure 1B, hysteresis of the 1700 kDa MeHA and softer PEG-PQ hydrogels was 
significantly higher than all other materials (p < 0.01; Figure 1B). Hysteresis of the AHA 
hydrogel was greater than that of the PEG-PQ and 35 kDa MeHA, despite having similar 
compressive moduli (p < 0.01). The volumetric swelling of the hydrogels after cross-linking 
was calculated to determine how well hydrogels would retain their molded dimensions. The 
1700 kDa MeHA hydrogels swelled significantly less and 35 kDa MeHA hydrogels swelled 
significantly more that PEG-PQ and AHA hydrogels (p < 0.01; Figure 1C). Because of the 
2× greater swelling in 35 kDa MeHA hydrogels, they were not used for cell encapsulation. 
MeHA refers to 1700 kDa MeHA throughout the remainder of this study.
Finally, hydrogels were digested in exogenous enzymes to verify the specificity of their 
degradation mechanism (Figure 1D). PEG-PQ hydrogels quickly degraded over a 4 h period 
when subject to collagenase but were unaffected by hyaluronidase for up to 24 h. 
Hyaluronan hydrogels were degraded with hyaluronidase but were unaffected by collagenase 
over the same time periods.
Hyaluronan Hydrogels Support 3D Culture of VICs with the RGDS Cell-Adhesive Ligand
VICs were first grown in 2D atop of PEG-PG and AHA hydrogels to determine if RGDS 
integrin ligand was required. Neither PEG-PQ and AHA scaffolds without PEG-RGDS 
supported strong VIC attachment as VICs formed round clusters of cells on the surface of 
the hydrogels after 7 days in culture (Supporting Information, Figure S2A,B). VICs readily 
adhered in 2D to PEG-PQ and hyaluronan scaffolds that had PEG-RGDS present for cell 
attachment after 7 days in culture (Supporting Information, Figure S2C–E). Therefore, when 
VICs were encapsulated in 3D, all scaffold materials contained 2 mM PEG-RGDS, and the 
healthy, spread morphology of VICs was evident and similar in all materials for at least 14 
days in culture (Figure 2A,B).
Expression of VIC activation marker αSMA expression was low in all hydrogel 
formulations as demonstrated through qPCR and IF staining (Figure 2C,D). The only 
location on hydrogels where strong αSMA stress fiber staining was observed was on the 
surface of the gels (Figure 2E). As expected, αSMA gene expression of VICs cultured on 
TCPS was significantly higher than for VICs encapsulated in all hydrogel formulations (n = 
16 TCPS, 9 AHA, 11 PEG-PQ, 8 MeHA, 4 soft PEG-PQ; p < 0.01; Figure 2F). VICs in 
MeHA and soft PEG-PQ also had significantly lower αSMA gene expression than did VICs 
in the stiffer PEG-PQ hydrogels (p < 0.01).
VICs demonstrated greater than 80% viability in PEG-PQ, AHA, and MeHA hydrogels, as 
shown by LIVE/DEAD staining after 3 and 7 days in 3D culture (Figure 3). Cells were more 
spread after 7 days, but cell numbers were not statistically different from day 3 to day 7. At 
day 7, the cell density is significantly higher (p < 0.05) in the MeHA hydrogels than in the 
AHA and PEG-PQ hydrogels (Figure 3H), but that is attributed to the faster hydrogel 
degradation, which resulted in lower imaged volume because the z-stack size was only 150 
µm compared to 200 µm for AHA and PEG-PQ samples.
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VICs Alter Hyaluronan-Related Gene Expression in Response to Hyaluronan Hydrogels
VICs expressed similar, very strong levels of CD44 in all hydrogel formulations (Figure 
4A,B). In contrast, VICs had very little RHAMM protein, showing only diffuse intracellular 
IF staining in all hydrogels (Figure 4C). qPCR was used to measure gene expression of 
CD44 and the hyaluronan synthases HAS1, HAS2, and HAS3 (Figure 4E–H; CD44 n = 12 
TCPS, 16 AHA, 11 PEG-PQ, 8 MeHA; HAS1–3 n = 8 TCPS, 8 AHA, 5 PEG–PQ, 8 
MeHA). There were no significant differences in gene expression of CD44 and HAS2 
between scaffold materials. HAS1 gene expression was significantly higher in VICs cultured 
in AHA than in PEG-PQ or on TCPS (p < 0.01). VICs in PEG-PQ hydrogels had 
significantly higher HAS3 expression than VICs in MeHA hydrogels (p < 0.05).
KIAA1199 Protein is Expressed in VICs
KIAA1199 gene expression was confirmed through qPCR in VICs grown in 2D on TCPS 
and 3D in PEG-PQ and hyaluronan hydrogels. KIAA1199 gene expression was significantly 
less in the MeHA and soft PEG-PQ hydrogels than on TCPS (Figure 4D; n = 6 TCPS, 8 
AHA, 9 PEG-PQ, 8 MeHA, 4 soft PEG-PQ; p < 0.01). The DNA sequence of qPCR 
products from VICs cultured on TCPS using the forward KIAA1199 primer is shown in 
Supporting Information, Figure S3A. A BLAST search of the sequenced qPCR product in 
the Sus scrofa genome confirmed predicted KIAA1199 nucleotide sequences (Supporting 
Information, Figure S3B).
VIC Enzyme Activity Remains Consistent across Hydrogel Material
Gelatin substrate and hyaluronan substrate zymography were used to identify enzyme 
activity of VICs encapsulated in hydrogels. VICs did not change their secreted gelatinase 
(MMP2 and MMP9) or hyaluronidase enzyme profile when cultured in either PEG-PQ or 
AHA hydrogels, as evidenced by zymogram band intensity (Figure 5A–D). Controls ensured 
that the clear bands observed in the hyaluronan substrate zymograms were from cell secreted 
hyaluronidase activity (Supporting Information, Figure S4). VICs cultured in media without 
serum secreted hyaluronidase enzymes that were active on the hyaluronan substrate at pH 
3.0 (Supporting Information, Figure S4A). While some of the observed enzyme activity is 
from hyaluronidase in the serum, hyaluronidase activity was also observed without serum in 
the media. Another potential problem was that protein may have been blocking alcian blue 
from staining the electrophoresis gel. To investigate that possibility, gels were developed at 
neutral pH. Protein bands were present at ∼50 kDa in both acidic and neutral pH cases, but 
the enzymes were not active at pH 7.8 and did not prevent alcian blue from staining the 
hyaluronan substrate (Supporting Information, Figure S4B). Bovine testicular hyaluronidase 
controls were active at pH 7.8.
Gene expression of hyaluronidase-1 (HYAL1), hyaluronidase-2 (HYAL2), and MMP-2 
enzymes from VICs cultured in different hydrogels were compared using qPCR (Figure 5E–
G). MMP-2 gene expression was significantly higher in VICs cultured in PEG-PQ hydrogels 
than TCPS or MeHA substrates (Figure 5E; n = 5 TCPS, 8 AHA, 5 PEG-PQ, 8 MeHA; p< 
0.01). There was no significant difference in HYAL1 expression between VICs grown on 
any substrate (Figure 5E; n = 12 TCPS, 13 AHA, 13 PEG-PQ, 8 MeHA; p > 0.8), which was 
consistent with zymography results. There was significantly lower HYAL2 gene expression 
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in VICs grown on TCPS compared to VICs grown in PEG-PQ or MeHA hydrogels (Figure 
5F; p < 0.01).
DISCUSSION
The layered structure of the ECM in natural heart valves has led engineers toward a layering 
approach to construct a biomimetic tissue engineered valve scaffold.9–12 In this study, 
hyaluronan hydrogels were utilized to represent the GAG-rich spongiosa layer of heart 
valves as part of a broader layering strategy. Hyaluronan was functionalized with acrylate 
(Scheme 1) and methacrylate (Scheme 2) groups to allow for photoinitiated free-radical 
polymerization, which was well tolerated by encapsulated cells (Figures 2 and 3). The 
mechanical properties of the hydrogels were successfully tuned to approximate both the 
mechanical properties and function of the spongiosa layer in the heart valve leaflet. To gain 
insight into the degree of biochemical signaling from the cross-linked hyaluronan scaffold, 
we studied behavior of VICs encapsulated in hyaluronan hydrogels compared to PEG-PQ 
hydrogels. Throughout the study, VICs demonstrated very similar behavior in both 
hyaluronan and PEG-PQ hydrogels. Similar levels of CD44 expression, KIAA1199 
expression, and hyaluronidase enzyme activity were observed in both materials. Results 
from gene expression analysis of the three isoforms of hyaluronan synthase enzymes showed 
that HAS1 expression was upregulated in AHA hydrogels, whereas HAS2 and HAS3 
expression were similar in AHA and PEG-PQ. Overall, the results of this study demonstrate 
that hyaluronan hydrogels can be tuned for the mechanical purpose of building complex 
tissue engineering scaffolds and can provide insight into the extent of biochemical signaling 
to encapsulated cells from cross-linked hyaluronan hydrogels.
The goal of this study was to compare behavior of VICs encapsulated in photo-cross-linked 
AHA versus PEG-PQ scaffold materials. Hyaluronan was functionalized at a low DOM to 
retain as much biological activity from the hyaluronan as possible. Seven percent DOM 
from the acrylation reaction resulted, on average, in one of every 14.3 disaccharides with a 
vinyl group, corresponding to ∼5400 Da of hyaluronan disaccharide between cross-links, 
independent of the molecular weight of the sodium hyaluronate used in the reaction. The 7% 
DOM is lower than reported DOM for other studies of VICs encapsulated in hyaluronan 
hydrogels.22,28 Because very little difference was observed between AHA and PEG-PQ 
scaffolds, hyaluronan was also methacrylated with only 2% DOM in order to maximize the 
biological availability of hyaluronan to encapsulated cells. The 2% DOM corresponds to 
having 1 in every 50 disaccharides functionalized or about 19000 Da of hyaluronan between 
cross-links. Additionally, larger molecular weight hyaluronan is more representative of the 
physiological molecule.38 The acrylation reaction did not have fine enough control to target 
2%, and we could not ion exchange 1700 kDa NaHA to a HA-TBA product that was soluble 
in DMF. Therefore, methacrylation was used to synthesize a cross-linkable hyaluronan 
molecule that most closely resembles the hyaluronan found in the natural heart valve (large 
molecular weight = 1700 kDa, low cross-linking density = 2% DOM).
The mechanical properties of photo-cross-linked hyaluronan hydrogels were comparable to 
native valve tissue. The bulk compressive modulus of the aortic valve leaflet was measured 
to be 5.13 ± 0.36 kPa, but this value includes compressive resistance of all three layers. Few 
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studies have isolated the mechanical properties of the spongiosa layer; a recently published 
report used atomic force microscopy to approximate Young’s modulus of the spongiosa 
layer to be in the 4–8 kPa range.39 We targeted the compressive modulus of the hyaluronan 
and PEGDA hydrogels to be between 2 and 3 kPa by varying polymer concentration and 
cross-linking time. The stiffness value was chosen based on our bulk compressive 
measurements of the whole leaflet, capabilities of the polymers that we were using, and 
comparison to previously published work that used hyaluronan hydrogels for VIC culture.22 
The 1700 kDa MeHA hydrogels were unable to be cross-linked to stiffnesses greater than 
∼1.6 kPa at 0.75% w/v. The 1700 kDa MeHA hydrogels could theoretically have been made 
more stiff with higher weight percentage of the polymer, but at higher weight percentage, the 
liquid was too viscous at physiological temperatures to be used effectively for cell 
encapsulation. PEG-PQ hydrogels that matched the compressive modulus of the 1700 kDa 
MeHA were constructed in order to determine if differences seen in VIC behavior 
encapsulated the 1700 kDa MeHA scaffolds were a result of bulk stiffness or due to the 
biochemical signaling from the hyaluronan scaffold.
Both 1700 kDa MeHA and AHA had significantly higher hysteresis than PEG-PQ and 35 
kDa MeHA and in the range of the measured 64.9% hysteresis of valve leaflets. The 
mechanical function of hyaluronan in the heart valve is one of lubrication and dampening.6,7 
Scaffolds with an increased level of hysteresis would serve these functions well, as 
hysteresis is a measure of energy dissipation. Therefore, either AHA or 1700 kDa MeHA 
would be appropriate materials to match the dampening function of the spongiosa layer. The 
proposed goal of lamination of the spongiosa hydrogel with other scaffold materials requires 
that the spongiosa layer swelling be minimized to prevent possible delamination and/or 
unnatural force distribution in the trilaminate scaffold. The 1700 kDa MeHA swelling was 
significantly less than the AHA or PEG-PQ materials, despite having lower DOM and 
compressive modulus. The reduced swelling is a result of the higher molecular weight of the 
hyaluronan molecule. Despite the same 2% DOM as the 1700 kDaA MeHA, the 35 kDa 
MeHA hydrogels had significantly greater swelling than had all other materials, rendering it 
unsuitable for a laminated heart valve scaffold prepared using our previously reported 
lamination strategy.12 Therefore, all following biological studies (zymography, qPCR, IF) 
did not use 35 kDa MeHA. Overall, the mechanical properties of the 2% DOM 0.75% w/v 
1700 kDa MeHA appear to be the best at supporting the mechanical requirements of the 
spongiosa layer. However, when VICs were cultured in 3D, the 1700 kDa MeHA scaffold 
degraded after only about 2 weeks. In comparison, the PEG-PQ and AHA hydrogels did not 
fully degrade for at least 4 weeks in culture.
VICs seeded in 2D atop both hyaluronan and PEG-PQ hydrogels without the RGDS peptide 
confirmed previous research showing that VICs require integrin ligands to attach to 
hydrophilic cross-linked scaffolds.22,25 Without RGDS, any viable VICs retained rounded 
morphology and clumped together rather than spread on the substrate (Supporting 
Information, Figure S2A,B). Therefore, all hydrogel formulations used for encapsulation 
contained 2 mM of PEG-RGDS for integrin binding. VICs were encapsulated throughout the 
hyaluronan scaffold during photo-cross-linking so that the cells did not need to adopt an 
invasive, disease-like phenotype in order to populate the interior of the scaffold.
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Immunofluorescent imaging and qPCR analysis demonstrated the relative expression of 
hyaluronan related proteins in VICs grown in 3D hydrogel culture. Hyaluronan-binding cell 
surface receptor CD44 was strongly present in VICs in either PEG-PQ or hyaluronan 
hydrogel scaffolds (Figure 4A,B). qPCR confirmed similar expression levels of the CD44 
gene, regardless of scaffold material (Figure 4E). Hyaluronan synthase gene expression was 
also very similar between hydrogel formulations, but interestingly HAS1 was upregulated in 
VICs cultured in AHA hydrogels compared to PEG-PQ hydrogels (Figure 4F). While HAS2 
has been studied in valves and is known to be required for proper valve development,40 there 
are no previously published reports of HAS1 expression in valve cells or tissue. In other 
types of fibroblasts, inflammatory factors IL-1β and TGF-β, as well as glycemic stress, have 
been shown to cause upregulation of HAS1 expression.41–43 HAS1 has also been implicated 
in malignant transformation of several types of cancer.44,45 Encapsulated VICs break down 
the scaffold as they elongate and migrate; the resulting cleaved hyaluronan fragments may 
induce an inflammatory response,46,47 as evidenced by upregulation of HAS1 in the AHA 
scaffold. Based on these results, further research into the VIC inflammatory response due to 
breakdown of cross-linked hyaluronan scaffolds is warranted.
This study confirmed the expression of the hyaluronan binding and depolymerizing peptide 
KIAA1199 in porcine aortic VICs. KIA1199 was studied in order to investigate another 
possible mechanism of hyaluronan binding and degradation in light of the weak 
hyaluronidase activity that was observed in zymography. KIAA1199 has been investigated in 
hearing loss,18 cancers,19 and dermal fibroblasts20 of humans, but has not been studied in 
porcine cells or in heart valves of any species. We have shown through qPCR that 
KIAA1199 is expressed in porcine aortic VICs (Figure 4D). The biological significance and 
role of KIAA1199 in valve cell and tissue function is still unknown, but our data suggests 
that less stiff substrates downregulate the expression of KIAA1199. For the least stiff 
scaffolds (1700 kDa MeHA and soft PEG-PQ) KIAA1199 gene expression was significantly 
less than it was for TCPS. Future work will be needed to demonstrate how porcine 
KIAA1199 is involved in hyaluronan catabolism in valve cells.
Although we had hypothesized that VICs would respond to the hydrogel scaffold by 
upregulating the enzymes that would degrade each scaffold material, zymography confirmed 
similar enzyme activity between VICs independent of substrate polymer makeup (Figure 
5A–D). The gelatin substrate zymogram showed strong MMP2 activity, while the 
hyaluronan substrate zymogram had bright bands at ∼52 kDa, corresponding to 
hyaluronidase 1, which is known to be activated at an acidic pH.46 Hyaluronidase 2 was not 
expected to be detected in conditioned media as it is tethered to the cell membrane by 
glycosylphosphatidyl-inositol.46 The zymograms also demonstrate that overall MMP 
activity was much stronger than hyaluronidase activity per mass of total protein from the 
conditioned media. Although the expression of hyaluronidase genes (HYAL1 and HYAL2) 
was the same between AHA and PEG-PQ hydrogels, mRNA expression of MMP2 was 
significantly higher in PEG-PQ hydrogels (Figure 5E–G), indicating some ability of the cells 
to control enzyme activity appropriate for the PEG-PQ scaffold. However, MMP activity is 
also heavily regulated by other enzymes, including tissue inhibitors of metalloproteinases 
(TIMPs), therefore, MMP2 gene expression is a less complete description of enzyme activity 
than the zymography results.
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The results of this study showed only subtle differences in VIC behavior between the AHA 
and PEG-PQ hydrogels, but previous research has shown that scaffold design has a 
noticeable effect on VIC behavior. For instance, substrate stiffness is known to play a role in 
VIC response to the scaffold,22 and VICs are highly dependent on integrin ligands for 
healthy, spread phenotype.30,48,49 To control these factors, we designed scaffolds from 
different materials, while maintaining consistent stiffness and PEG-RGDS concentration. 
The corresponding consistency in our results may indicate that stiffness and adhesive ligand 
presentation are the most influential factors to guide VIC behavior, rather than the specific 
material substrate. Furthermore, although hyaluronan DOM was targeted to be low (7 or 
2%), cross-linking may still have rendered the hyaluronan hydrogel biochemical inert to 
hyaluronan receptors. Research has demonstrated that CD44-hyaluronan interactions are a 
multivalent process, requiring large fragments of hyaluronan and clustering of CD44 to 
maintain the bound state.50,51 The results of this study suggest that cross-linked hyaluronan 
scaffolds, at even lower DOM, may render the hyaluronan unavailable for the complex 
interactions necessary to bind with CD44.
Although we have proposed using hyaluronan hydrogels as part of a tissue engineered heart 
valve scaffold, these results presented here should be interpreted in the appropriate context. 
To begin, all data was acquired from statically cultured samples, without applied mechanical 
stimulation. Heart valves normally experience cyclic tension, shear, compression, and 
bending forces continuously throughout their lifetime, so understanding how cells in the 
spongiosa layer react to physiologically relevant forces and motion is an important research 
goal. While hyaluronan makes up 60% of the GAGs in valve tissue, the natural valve 
spongiosa layer also contains other important biological molecules, such as sulfated GAGs, 
proteoglycans, and elastic fibers.52 A scaffold intended to mimic all of the key biochemical 
features of the spongiosa layer would need to account for this additional complexity. 
Additionally, previous research found increased elastin secretion by VICs in hyaluronan 
scaffolds with the addition of exogenous hyaluronidase enzymes, small hyaluronan 
fragments, or culture times of up to 6 weeks.24,26,28 We were not able replicate these results 
without addition of exogenous factors, although in this study VICs were only cultured for up 
to 4 weeks.
Finally, although we investigated several hyaluronan hydrogel formulations, there still 
remain opportunities to identify whether modulating a combination of polymer 
functionalization, DOM, stiffness, RGDS concentration, and hydrogel weight fraction can 
significantly alter VIC behavior in the hydrogels. Strategies to make the hyaluronan 
backbone or digested hyaluronan fragments more available for cellular processing may lead 
to changes in cell signaling from the scaffold material. The mechanical properties of the 
AHA and PEG-PQ scaffolds were fine-tuned by modulating cross-linking time. However, 
under-cross-linking will leave free acrylate groups in the hydrogel. While the acrylate 
groups are unlikely to affect cell viability,53 they may react with biological molecules and in 
turn have an effect on cell behavior in an unpredictable manner. To mitigate this possibility, 
mechanical properties could also be adjusted by changing the polymer weight fraction, but 
we had better fine control over final compressive modulus by changing cross-linking time, 
rather than polymer weight fraction.
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CONCLUSIONS
Photo-cross-linked hyaluronan hydrogels were investigated for use in a layered, synthetic, 
tissue-engineered heart valve. The mechanical properties of hyaluronan-based hydrogels 
were tuned to match the mechanical purposes of the valve spongiosa layer. VICs cultured in 
hyaluronan demonstrated only subtle differences compared to those cultured in PEG-based 
scaffolds. These results suggest that factors such as scaffold stiffness or RGDS integrin 
ligand concentration may be far more influential than hydrogel polymer formulation for 
directing VIC behavior. However, the results may also suggest that cross-linking the 
hyaluronan renders it less biochemically available for cell signaling. In either case, cross-
linked hyaluronan was shown to be a tunable scaffold material that promotes the quiescent, 
healthy phenotype of VICs in 3D culture and can be used as part of a broader layering 
strategy for heart valve tissue engineering.
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Figure 1. 
Mechanical characterization of cross-linked hydrogels. (A) Bulk compressive modulus of 
PEG-PQ and hyaluronan variants. 1700 kDa MeHA and soft PEG-PQ had significantly 
lower compressive modulus than others (p < 0.01). (B) Hysteresis during compression; 1700 
kDa MeHA, soft PEG-PQ and AHA had significantly greater hysteresis than others with 
1700 kDa MeHA and soft PEG-PQ significantly higher than AHA (p < 0.01). (C) 
Volumetric swelling ratio overnight in PBS demonstrates dimensional change after cross-
linking. Swelling for the 35 kDa MeHA was significantly greater than all others (p < 0.01); 
swelling for the 1700 kDa MeHA was significantly less than all others (p < 0.05; bars that 
do not share a common letter are statistically different from each other). (D) Lyophilized 
mass of enzyme-digested hydrogels over 24 h demonstrated susceptibility and specificity of 
PEG-PQ and AHA hydrogels to collagenase and hyaluronidase. Collagenase degraded only 
PEG-PQ hydrogels and hyaluronidase degraded only AHA hydrogels.
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Figure 2. 
(A, B) 100 µm maximum intensity z-projection of VICs encapsulated for 14 days in (A) 
PEG-PQ and (B) AHA hydrogels; blue = DAPI; green = F-actin; scale = 100 µm. (C, D) 
Faint, diffuse αSMA expression in interior of hydrogels; 30 µm maximum intensity z-
projection of VICs inside (C) PEG-PQ and (D) AHA hydrogels. (E) The only strong positive 
staining for αSMA stress fibers was on the surface of hydrogel (15 µm maximum intensity 
z-projection); blue = DAPI; green = αSMA; scale = 20 µm. (F) Gene expression of αSMA; 
TCPS αSMA expression was significantly greater than in 3D hydrogels (p < 0.01); 1700 
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kDa MeHA αSMA expression was less than PEG-PQ (p < 0.05; bars that do not share a 
common letter are significantly different from each other).
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Figure 3. 
Representative LIVE/DEAD staining of VICs at (A, C, E) day 3 and (B, D, F) day 7 
postencapsulation. 200 µm maximum intensity z-projections of VICs encapsulated in (A, B) 
PEG-PQ, (C, D) AHA, and (E) MeHA hydrogels; (F) 150 µm maximum intensity z-
projection in MeHA hydrogels; green = live; red = dead; scale = 50 µm. (G) Encapsulated 
VICs had greater than 80% viability in all hydrogel formulations. (H) Total cell density 
remained consistent from day 3 to day 7. At day 7, there was a significantly higher density 
of VICs in MeHA hydrogels than PEG-PQ and AHA hydrogels (p < 0.05).
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Figure 4. 
After 14 days in culture, VICs in both (A) PQ and (B) AHA hydrogels showed similar, 
ubiquitous CD44 expression (90 µm maximum intensity z-projection); blue = DAPI; red = 
CD44; scale = 20 µm). (C) Only weak, diffuse intracellular RHAMM was seen in AHA 
hydrogels (50 µm maximum intensity z-projection); blue = DAPI; red = RHAMM; scale = 
20 µm. (D) Gene expression of protein KIAA1199 in VICs grown on TCPS was 
significantly greater than VICs grown in 1700 kDa MeHA and soft PEG-PQ hydrogels, 
demonstrating that stiffness might play a role in KIAA1199 expression (*p < 0.05). (E–H) 
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CD44 and hyaluronan synthase (HAS1, HAS2, HAS3) gene expression was similar in all 
scaffolds, except for AHA HAS1 expression, which was significantly greater than both 
TCPS and PEG-PQ (p < 0.01). HAS3 expression was also significantly greater in PEG-PQ 
than MeHA (*p < 0.05).
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Figure 5. 
Zymograms to detect enzyme activity in conditioned media. (A) Gelatin substrate 
zymography detects strong MMP2 activity, however, there is (B) no statistically significant 
difference between cells grown in PEG-PQ or AHA hydrogels. (C) Hyaluronan substrate 
zymography detects strongest enzyme activity (HYAL1) at just above 50 kDa; there is (D) 
no difference in hyaluronidase enzyme activity between cells grown in PEG-PQ or AHA 
hydrogels. (E–G) Gene expression of MMP2, HYAL1, and HYAL2 enzymes. (E) MMP2 
expression was significantly higher in PEG-PQ hydrogels than TCPS and MeHA (*p < 
0.01); (F) HYAL1 expression was similar in all scaffolds; (G) VICs grown on TCPS have 
significantly lower HYAL2 expression than VICs grown in PEG-PQ or MeHA hydrogels (*p 
< 0.01).
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Scheme 1. 
Functionalization of Hyaluronan Polymers for Free-Radical Cross-Linking with Acrylate 
Groups Using Acryloyl Chloride Overnight in DMF
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Scheme 2. 
Functionalization of Hyaluronan Polymers for Free-Radical Cross-Linking with 
Methacrylate Groups Using Glycidyl Methacrylate for 5 Days in PBS
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